SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
BioSig Technologies, Inc. (BSGM) .
Criteria proven by this page:
- VALUE (10/100, Fail) — analyst consensus target implies downside from the current price ($0.41, 93.3%).
- Analyst consensus target $0.41 (-93.3% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 27/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
10/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BSGM
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio21,413.67
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.07
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$0.41 (-93.3%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-1.68 |
$0.00 |
$-9.46M |
- |
| 2016 |
$-1.49 |
$0.00 |
$-11.59M |
- |
| 2017 |
$-1.24 |
$0.00 |
$-12.7M |
- |
| 2018 |
$-1.19 |
$0.00 |
$-17.25M |
- |
| 2019 |
$-1.64 |
$0.00 |
$-33.92M |
- |
| 2020 |
$-1.87 |
$0.00 |
$-52.17M |
- |
| 2021 |
$-0.94 |
$441K |
$-31.36M |
-7111.6% |
| 2022 |
$-0.63 |
$286K |
$-27.27M |
-9535.3% |
| 2023 |
$-0.40 |
$18K |
$-29.04M |
-161338.9% |
| 2024 |
$-0.07 |
$40K |
$-10.33M |
-25825% |
